Mazor Robotics, an innovator of innovative surgical robots and complementary products recently declared that its Renaissance platform has achieved U.S. FDA marketing clearance for better performance of brain surgery.
The addition of precise positioning of surgical instruments and implants while performing brain surgery has expanded the applications of the Renaissance system.
A surgical guidance system called ‘the Renaissance technology’ was originally designed for application in spine surgeries. This novel technology system from Mazor Robotics is ideal for incorporating in brain procedures for carrying out several functions such as neurostimulation electrode placement for DBS (deep brain stimulation), biopsies, and shunt placements. The Renaissance System ensures high precision, ease-of-use, and safety profile, and therefore ensures effective use as a frameless treatment solution for brain procedures. Renaissance has a successful long-term history of being deployed in most of the clinical brain surgical procedures performed in Europe. Renaissance so far has been implemented in around 34 hospitals around the world for efficiently conducting different types of spine surgery.
According to the CEO of Mazor Robotics, Ori Hadomi, with focus on spine surgery at present, the innovative Renaissance technology can be further expanded to advance other surgical procedures as well. Neurosurgeons concentrate on both the spine and brain, where brain surgeries signify an extensive market opportunity associated with Mazor’s current focus. By receiving the U.S. regulatory clearance recently, Mazor can better support the neurosurgeons to advance brain surgery and the resulting clinical outcomes as well.